Inhibitor analysis for Alzheimer’s points towards a polypharmacology approach: abstract highlights from PharmSci360 day 3
Member Exclusive News
News, Computational chemistry and informatics, Novel lead compounds, Therapeutic targets, Drug repurposing, Neurological & Psychiatric , Infectious , Cancer
Increasing predictability in drug discovery using nanoinformatics: an interview with Yosi Shamay
A peek behind the paper: compound optimization monitor (COMO) for computational evaluation of lead optimization
A GPS for chemists: machine-learning algorithm predicts chemical reactions
Study demonstrates capability of generative reinforcement learning in drug discovery
Ask the experts: what do the next 5—10 years look like for artificial intelligence?
Ask the experts: is there too much hype surrounding the promise of artificial intelligence?
Ask the experts: how can artificial intelligence address some of the problems faced by drug discovery?
Ask the experts: what impact has artificial intelligence already had on drug discovery?
A step towards making AI accessible to all researchers: an interview with John Overington